SSShefali Srivastava

Shefali Srivastava

*This is an algorithmically generated author record based on publicly available information.

Shefali Srivastava has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Andrographolide-A Magical Bioactive Compound: An Overview

    by Ajay Kumar Shukla, Vimal Kumar Yadav, Rahul Kumar Maurya, Rahul Mishra, Shefali Srivastava, Manoj Kumar Mishra

    Andrographis paniculata (ANP) is a medicinal plant containing several bioactive compounds, such as diterpenoids, flavonoids, and polyphenols. Andrographolide is one of the key natural compounds which are found in the Andrographis paniculata plant. It has been used as an Immunomodulators, antiviral, anti-inflammatory, analgesic, anti-cancer, hepatoprotective, cardioprotective, and managing COVID-19, chikungunya virus (CHIKV) infections etc, due to the key bioactive compound Andrographolide; therefore, this molecule called a magic bioactive molecule. Many people have cured and increased their immunity by regularly taking this herb in the form of tea. All of these potential properties of this bioactive molecule make it very unique. Therefore, there needs to be more research work for the development of novel properties and future prospects.


  • A Review on Osteoarthritis and its Eradication Approaches: An Update

    by Prasoon Pandey, Ritika Singh, Shefali Srivastava, Manoj Kumar Mishra

    Osteoarthritis (OA) is a disease characterized by degeneration of cartilage or wear and tear. OA is a cause of disability and health issues. It is a disease that affects more than 500 million adults annually worldwide, of which India accounts for about 22 to 39% of OA patients. The most common type of osteoarthritis is knee OA. Pathogenesis of OA requires evolution in basic science and clinical research to enhance our understanding of the pathogenesis and as well as different treatment options. It is mainly classified as primary and secondary OA. The treatment for OA can only reduce the symptoms and cannot cure the disease itself, including pharmacological treatment, like non-steroidal anti-inflammatory drugs (NSAIDs), acting on COX1 (cyclooxygenase 1) and COX2 (cyclooxygenase 2) enzymes. Non-pharmacological treatments for OA include exercise like walking, and aerobic exercise, diet, weight loss, hot and cold therapy, as well as electrotherapy, which improves muscle strength and decreases joint pain. Surgical treatment is the last treatment option for OA patients, which includes arthroscopy and joint replacement therapy. Thus, necessary precautions should be taken for joints to be healthy and disease-free.